FAF
ABMD
Fjarde Ap-fonden’s Abiomed Inc ABMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,385
| Closed | -$2.57M | – | 559 |
|
|
2022
Q3 | $2.57M | Hold |
10,385
| – | – | 0.03% | 471 |
|
|
2022
Q2 | $2.57M | Sell |
10,385
-2,100
| -17% | -$520K | 0.03% | 471 |
|
|
2022
Q1 | $4.14M | Buy |
12,485
+300
| +2% | +$99.4K | 0.04% | 433 |
|
|
2021
Q4 | $4.38M | Buy |
12,185
+200
| +2% | +$71.8K | 0.04% | 439 |
|
|
2021
Q3 | $3.9M | Sell |
11,985
-1,900
| -14% | -$618K | 0.04% | 465 |
|
|
2021
Q2 | $4.33M | Sell |
13,885
-1,200
| -8% | -$375K | 0.04% | 455 |
|
|
2021
Q1 | $4.81M | Buy |
15,085
+1,100
| +8% | +$351K | 0.04% | 420 |
|
|
2020
Q4 | $4.53M | Sell |
13,985
-300
| -2% | -$97.3K | 0.04% | 409 |
|
|
2020
Q3 | $3.96M | Buy |
14,285
+1,200
| +9% | +$332K | 0.04% | 410 |
|
|
2020
Q2 | $3.16M | Sell |
13,085
-400
| -3% | -$96.6K | 0.04% | 435 |
|
|
2020
Q1 | $1.96M | Buy |
13,485
+600
| +5% | +$87.1K | 0.03% | 480 |
|
|
2019
Q4 | $2.2M | Buy |
12,885
+3,200
| +33% | +$546K | 0.03% | 544 |
|
|
2019
Q3 | $1.72M | Sell |
9,685
-1,272
| -12% | -$226K | 0.02% | 547 |
|
|
2019
Q2 | $2.85M | Sell |
10,957
-1,400
| -11% | -$365K | 0.04% | 480 |
|
|
2019
Q1 | $3.53M | Buy |
12,357
+2,516
| +26% | +$719K | 0.04% | 419 |
|
|
2018
Q4 | $3.2M | Sell |
9,841
-1,900
| -16% | -$618K | 0.06% | 346 |
|
|
2018
Q3 | $5.28M | Sell |
11,741
-200
| -2% | -$90K | 0.08% | 276 |
|
|
2018
Q2 | $4.88M | Buy |
+11,941
| New | +$4.88M | 0.07% | 290 |
|